Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Cell and Stem Cell(Electronic Edition) ›› 2019, Vol. 09 ›› Issue (01): 54-57. doi: 10.3877/cma.j.issn.2095-1221.2019.01.011

Special Issue:

• Review • Previous Articles     Next Articles

Application of cardiosphere-derived cells in ischemic heart failure

Jiarun Lin1, Lianming Liao2,()   

  1. 1. Clinical Medical College, Guizhou Medcial University, Guiyang 550000, China; Center of Laboratory Medicine, Union Hospital of Fujian Medical University, Fuzhou 350001, China
  • Received:2018-10-10 Online:2019-02-01 Published:2019-02-01
  • Contact: Lianming Liao
  • About author:
    Corresponding author:Liao Lianming, Email:

Abstract:

Acute cardiac infarction is caused by acute cardiac ischemia due to stensis of coronary artery and its branches. Serious cardiac ischemia may cause necrosis of heart cells and scar around the infarction area may cause heart dysfunction and remolding, leading to heart faiure. Stem cells derived from cardiac tissue itself, referred to as cardiosphere-derived cells (CDCs), may give rise to muscular cells and vascular endothelial cells in vitro and trigger native cardiomyocyte proliferation and recruitment of endogenous progenitor cells via paracrine effects. Mediators involved in paracrine signaling can be used as a stem cell-free therapy, with all the benefits and none of the associated complications of stem cells. Large-scale clinical trials are needed to confirm the long-term efficacy of CDC.

Key words: Myocardial infarction, Heart failure, Stem cells, Cardiosphere-derived cells

京ICP 备07035254号-3
Copyright © Chinese Journal of Cell and Stem Cell(Electronic Edition), All Rights Reserved.
Tel: 0086-591-87982783 E-mail: ccsct@vip.163.com
Powered by Beijing Magtech Co. Ltd